Loading clinical trials...
Loading clinical trials...
The Response and Outcomes of Pegylated Interferon Plus Ribavirin Combination Therapy for Chronic Hepatitis C Patients Concomitant With Hepatocellular Carcinoma
Conditions
Interventions
peginterferon alpha-2a and ribavirin
Locations
1
Taiwan
Kaohsiung Medical University Hospital
Kaohsiung City, Taiwan
Start Date
January 1, 2007
Primary Completion Date
December 1, 2009
Completion Date
February 1, 2010
Last Updated
February 15, 2010
NCT07485114
NCT06345508
NCT06811116
NCT06066138
NCT04380545
NCT07291076
Lead Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions